PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

30 Dec 2015 07:00

RNS Number : 3752K
Arria NLG PLC
30 December 2015
 

30 December 2015

Arria NLG plc

 ("Arria NLG" or the "Company")

 

Grant of share options

 

Arria NLG (AIM: NLG), a leader in the development and deployment of Natural Language Generation ("NLG") technologies, has yesterday granted, under the Company's long term incentive plan (the "LTIP"), options to purchase up to 4,550,000 ordinary shares of the Company at an exercise price of £0.001 per share (the "LTIP Options"). The four recipients who are US taxpayers will receive their option grants as of 1 January 2016. The awards are being made to senior members of the Company's management team to acknowledge outstanding personal contributions and achievement. Participants in the LTIP include the Company's three chief scientists, Dr. Robert Dale, Dr. Ehud Reiter and Dr. Yaji Sripada, and a director of the Company, Wayne Thornhill, Chief Financial Officer.

 

The awards are made as Restricted Stock Units under the LTIP, details of which were set out in the Company's AIM Admission Document dated 5 December 2013, and will represent approximately 1.1 per cent. of the Company's issued share capital. 42 per cent. of the LTIP Options (1,903,958 shares) are fully vested upon the date of the award and the balance of the LTIP Options (2,646,042 shares) will be subject to Company success criteria and will vest, if at all, progressively over the next two years. The performance criteria are divided between a Company revenue target and individual executive performance conditions, as determined by the Company's Remuneration Committee.

 

Executive Director and Chief Financial Officer Wayne Thornhill has been granted 1,500,000 LTIP Options, representing approximately 0.4 per cent. of the issued ordinary share capital, and therefore Mr Thornhill now holds options over a total of 1,850,000 ordinary shares of the Company.

 

 

For further information, please visit www.arria.com or contact:

Arria NLG plc

Stuart Rogers

Chairman and Chief Executive

 

Tel +44 (0)20 7100 4540

Allenby Capital

Nominated Adviser & Joint Broker

Nick Naylor

Jeremy Porter

James Reeve

 

Tel: +44 (0)20 3328 5656

MSL Capital Markets - Lead Manager

Andrew McDouall

Justine Dunnett

Peter Lynds

 

Tel: +64 (0)4 472 2716

Westhouse Securities - Joint Broker

Antonio Bossi

Robert Finlay

Tel: +44 (0)20 7601 6100

IFC Advisory - Financial PR and IR

Tim Metcalfe

Graham Herring

Heather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

heather.armstrong@investor-focus.co.uk

Ruder Finn - PR (USA)

Scott Beaver (West Coast)

Brianna Mulligan (East Coast)

 

Tel: +1 541-326-5847

Tel: +1 203-246-1304

 

Arria NLG

 

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software, specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the Data2Text Founders at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLKLLLELFBFBB
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.